Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complex
Molly C. McNamara(Harvard University), Brendan D. Manning(Cancer Research Center), Margaret E. Torrence(Harvard University), Alexander J. Valvezan(Rutgers, The State University of New Jersey), Elizabeth P. Henske(Brigham and Women's Hospital), Ting C. Zhao(Zhejiang Chinese Medical University), Aaron M. Hosios(Massachusetts Institute of Technology), Meghan E. Wilkinson(Harvard University), Cameron Fraser(Harvard University), Kristopher A. Sarosiek(Harvard University), David J. Kwiatkowski(Brigham and Women's Hospital), Chin‐Lee Wu(Massachusetts General Hospital)
Cited by 5
Related Papers
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|860
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
|Science|2015|718
Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib
|JAMA Oncology|2018|689
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
|Nature Medicine|2014|664
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656